A Global Overview of Tuberculosis Vaccine Development
-
Published:2022-12-01
Issue:2
Volume:9
Page:47-55
-
ISSN:1727-3706
-
Container-title:Vaccine Research
-
language:en
-
Short-container-title:vacres
Author:
Rahimi Erfan,
Kariman Arian,
Sheikhpour MojganORCID
Publisher
Apex Publishing
Reference86 articles.
1. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical microbiology reviews. 2003;16(3):463- 96 .
2. Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E et al. Cutaneous mycobacterial infections. Clinical microbiology reviews. 2018;32(1):e00069-18 .
3. Van Den Berg RA, De Mot L, Leroux-Roels G, Bechtold V, Clement F, Coccia M et al. Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72/AS01 in bacillus Calmette–Guérin-vaccinated adults. Frontiers in immunology. 2018;9:564 .
4. Zomorodbakhsh S, Abbasian Y, Naghinejad M, Sheikhpour M. The effects study of isoniazid conjugated multi-wall carbon nanotubes nanofluid on Mycobacterium tuberculosis. International journal of nanomedicine. 2020:5901-9 .
5. Sheikhpour M, Barani L, Kasaeian A. Biomimetics in drug delivery systems: A critical review. Journal of Controlled Release. 2017;2 .109-53:97